SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences soars on commencing production for manufacture of Hydroquinone & Catechol

21 Sep 2020 Evaluate

Camlin Fine Sciences is currently trading at Rs. 96.75, up by 4.30 points or 4.65 % from its previous closing of Rs. 92.45 on the BSE.

The scrip opened at Rs. 92.25 and has touched a high and low of Rs. 97.05 and Rs. 91.00 respectively. So far 95903 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 100.90 on 27-Aug-2020 and a 52 week low of Rs. 33.40 on 25-Mar-2020.

Last one week high and low of the scrip stood at Rs. 98.55 and Rs. 89.00 respectively. The current market cap of the company is Rs. 1176.77 crore.

The promoters holding in the company stood at 22.74%, while Institutions and Non-Institutions held 20.12% and 57.14% respectively.

Camlin Fine Sciences has successfully commenced the commercial  production  for manufacture of Hydroquinone and Catechol on September 21, 2020 at the company’s newly set  up Diphenol manufacturing plant situated  at  Dahej SEZ, District Bharuch, Gujarat.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

132.30 -4.05 (-2.97%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×